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Abstract 
Medication errors and adverse drug reactions are prevalent across the healthcare continuum. 
As many as 4.6% of deaths in the United States may be the result of an adverse drug reaction, 
making them one of the top five leading causes of death.  Accurate medication reconciliation is 
one method to help protect patients from adverse medication reactions.  Medication 
reconciliation is a formal process that is used by health care providers to gather a complete and 
accurate medication list to identify discrepancies, inform prescribing decisions and identify and 
prevent medication errors.  This DNP project involved the implementation of an evidence-based 
medication reconciliation protocol with a sample of twenty-five patients at a community-based 
outpatient psychiatric practice in Western Massachusetts.  Results indicated that there were a 
significant number of both prescribed and over the counter medications missing from the 
patient’s electronic medical record medication profile as well as a high number of potential drug 
interactions.  Staff education about the process of medication reconciliation was an important 
aspect of this project.   
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Medication Reconciliation in an Ambulatory Care Community Mental Health Practice 
Whether admitted to an inpatient facility or as an outpatient in a medical practice, the 
importance of maintaining accurate medication lists cannot be understated.  With the majority of 
medication, errors occurring during transitions of care between providers (Nassaralla, et al., 
2008) patients in outpatient practices are left vulnerable to errors.  Psychiatric patients are 
particularly susceptible as it not uncommon for them to be on combinations of both psychiatric 
and general medical drugs to treat both mental illness as well as comorbid medical conditions 
(Simoons, et al., 2016).   
Background 
Adverse Drug Events 
Medication errors and their potential associated adverse drug events are a serious 
problem in acute care facilities, skilled nursing facilities, provider practices and in the home.  
Adverse drug events (ADE) account for nearly 700,000 emergency department visits and 
100,000 hospitalizations each year, and they affect nearly five percent of hospitalized patients 
which makes them one of the most common types of inpatient errors.  Due to lack of structured 
reconciliation processes, ambulatory patients may experience ADEs at even higher rates (Agency 
for Healthcare Research and Quality [AHRQ], 2015).  Adverse drug reactions cost $136 billion 
yearly which is an amount that is greater than the total costs of cardiovascular or diabetic care 
(U.S. Food and Drug Administration, 2016).  The highest risks for discrepancies occur during 
discharge from acute care facilities to home where studies estimate that anywhere from 14.1% to 
94% of patients experience at least one medication discrepancy (Fuji, M, & Abbott, 2014).  As 
many as 4.6% of deaths in the United States may be the result of an adverse drug reaction, 
making them one of the top five leading causes of death (Bourgeois, Shannon, Valim, & Mandl, 
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2010).    
With lengths of stay in U.S acute care hospitals steadily decreasing since 1960 (Kalra, 
Fisher, & Axelrod, 2010), the reliance on outpatient providers for disease management and 
prescribing has increased.  More than 80% of adults in outpatient settings report using at least 
using one medication, and approximately 70% of outpatient clinic visits in the United States 
have been associated with the prescription or continuation of a medication.  In addition, the 
proportion of patients taking five or more medications more than doubled between 1995 and 
2005 (Bourgeois et al., 2010).   
With increasing use of prescription medications, polypharmacy as well as an increasing 
elderly population (ADEs have increased among patients 65 years and older with as many as one 
in twenty persons seeking medical care for an ADE), the potential risk of ADEs has also 
increased.  Findings from an 11-year national study on adverse drug events revealed that overall, 
outpatient adverse drug reactions resulted in a mean yearly total of 107,468 hospital admissions.  
Therefore, measures must be developed to monitor and prevent ADEs in the outpatient 
population (Bourgeois et al., 2010).   
Barnsteiner (2008) summarized findings from two studies that addressed discrepancies in 
outpatient medical records:  Among the findings, one study reflected discrepancies in 26.3% of 
charts of patients who were requesting precription medications; of those, 59% involved omitted  
medications from the electronic list.  A second study in an ambulatory family practice found that 
among the 76% of patients in the practice who had medications prescribed, 87% of the charts 
had incomplete or missing documentation of those medications.   
As mentioned previously, psychiatric patients are particularly susceptible to medication 
errors.  In a study of medication reconciliation, Simoons, et al., (2016) found at least one 
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discrepancy in 94.8% of patients among four outpatient departments for mood and anxiety 
disorders with almost twenty-three percent of all discrepancies having the potential to cause 
“moderate to severe discomfort or clinical deterioration, affecting almost half of all patients” (p. 
1516).    
Medication Reconciliation 
 The Institute of Medicine (2001) defined The Six Domains of Health Care Quality, and 
one of those aims was that health care must be safe.  Providing safe care involves avoiding harm 
to patients from the care that is intended to help them (AHRQ, 2001).  Accurate medication 
reconciliation is an essential process in helping protect patients from adverse drug events and 
keeping patients safe.  Medication reconciliation is such an important process that the World 
Health Organization named it as one of five top patient safety strategies (McCarthy, et al., 2016).    
Medication reconciliation is a formal process that is used by health care providers to 
gather a complete and accurate medication list (both home and prescribed) to identify 
discrepancies, inform prescribing decisions and identify and prevent medication errors (AHRQ, 
2013).  The design of medication reconciliation centers around the concept of creating a single 
list of the patient’s current list of medications which AHRQ (2012), describes as the "one source 
of truth." that can be accurately shared and utilized by all physicians, nurses, pharmacists, and 
others caring for the patient.  “The reconciling process has been demonstrated to be a powerful 
strategy to reduce medication errors as patients move from one level of care to another” (IHI, 
2011, p. 6).     
When medication reconciliation cannot be performed in the medical office, it may be 
necessary to execute it in the patient’s home.  This is especially important when a patient is 
homebound due to multiple medical comorbidities.  Fuji, M, & Abbott (2014) suggest that when 
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medications have to be reconciled in the home, a timeline should be set for completion of the 
process, a time should be set for when the process shall occur, a checklist and forms should be 
created as needed to guide the process.   
Problem Statement 
 Medication errors and adverse drug events (ADE) cost billions of dollars a year, lead to 
readmissions and increased lengths of stay, and most importantly, cost patient lives.  The risk of 
adverse outcomes increases with absent, incomplete or inaccurately completed medication 
reconciliations.  The quality improvement project proposed, involves the implementation of an 
evidence-based protocol to improve the process of medication reconciliation in an outpatient 
psychiatric practice.   
Organizational “Gap” Analysis of Project Site  
 The location for this quality improvement project was a community-based outpatient 
psychiatric practice in Western Massachusetts where the majority of patients are adults, many of 
whom have comorbid medical conditions.  The current medication reconciliation process at this 
practice is inefficient.  Licensed Social Workers (LICSW) and therapists collect medication 
information when they complete an initial intake with a patient in the office or on subsequent 
visits in the patient’s home.  Most of the social workers and therapists have no medical 
background and thus, do not always put much emphasis on the mediation reconciliation portion 
of the intake.  Social workers and therapists also have no training in the area of pharmacology, so 
it’s difficult for them to identify, properly categorize or select the correct formulation of each 
medication in the list (caps, pills, liquid).  If a medication list is incomplete on the first visit to a 
practice, if it is not reconciled correctly on a subsequent visit, the medical record remains 
incorrect and opens a patient up to the potential risk of adverse outcomes.   
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Review of the Literature 
 Databases and sites searched in this literature review (see Appendix C) included 
CINAHL, PubMed, Agency for Healthcare Research and Quality (AHRQ) and Institute for 
Healthcare Improvement (IHI).  Keywords used included medication reconciliation, outpatient, 
psychiatric, ambulatory care with inclusion criteria 2008-2017 and English language.  For 
purposes of this draft, five studies and two evidence-based protocols were chosen from the IHI 
and the AHRQ.  
 Nassaralla, et al., (2008) and (Keogh, et al., 2016) conducted studies based on the 
implementation of interventions to improve medication reconciliation completion compliance in 
ambulatory care settings.  Nassaralla, et al., (2008) implemented their intervention and conducted 
their study across four academic, ambulatory primary care clinics.  Before the intervention, 
baseline data that assessed the completeness, correctness and accuracy of medication 
documentation in the electronic health record (EHR).  Interventions that included staff training 
and patient education to increase awareness were implemented.  Completeness of medication 
lists improved from 20.4% pre-intervention to 50.4% post-intervention, and patient participation 
in the medication reconciliation process increased from 13.9% to 33%; lastly, medication list 
accuracy improved from 11.5% to 29%.   
 Keogh, et al., (2016) implemented a 24-month medication reconciliation improvement 
process across 148 ambulatory care practices in one health care system.  Three levels of 
interventions that centered on staff education were implemented; a more intensive intervention 
was implemented at 65 specialty practices; a modified approach was implemented at 71 other 
specialty practices, and a less intensive approach was used at 14 primary care practices.  The 
level of intervention varied based on practice infrastructure and prescription rates.  Two 
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measures were used: measure one, the percentage of active medications prescribed by that 
provider that were reconciled and measure two, how often all medications that were prescribed 
by the provider were reconciled.  From pre to post-intervention, measure one improved from 
71% to 90% in specialty practices and from 62% to 91% in primary care practices.  Measure two 
across all ambulatory practices increased from 81% to 90%.  All interventions, which focused 
heavily on staff education as well as better informing patients about the medication 
reconciliation processes, showed improved outcomes. 
 Milone, Philbrick, & Harris, (2014) included a pharmacist in their intervention in 
determining the incidence of medication discrepancies in the EHR of an outpatient family 
medical clinic.  Before seeing the physician, the clinical pharmacist consulted with each patient 
and reviewed their medication list and made corrections as necessary.  During the one-year study 
period, a total of 327 patients were seen by the pharmacist for reconciliation, and 2,167 
discrepancies were identified and resolved.  Of the discrepancies found, 51.1% were determined 
to be clinically important by the pharmacist.  This study highlights the benefits of including a 
clinical pharmacist in the medication reconciliation process in outpatient practices.   
 Sarzynski, Luz, Rios-Bedoya, & Zhou, (2014) conducted a pilot study using a ‘brown 
bag’ method to improve the medication reconciliation process.  Forty-six cognitively intact 
elders at a university-affiliated community practice were the subjects.  Half of the participants 
were asked to ‘brown bag' (bring their medication bottles with them to the appointment), and the 
other half were ‘non-brown baggers.'  Results showed that most of the ‘brown baggers' did not 
bring all their medications to their appointment, therefore, chart list accuracy was no better for 
‘brown baggers' vs. ‘non-brown baggers.'  The authors suggest that bringing medications may 
prompt providers to conduct a more thorough medication history; however, regardless of 
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bringing medications to office visits, structured interviewing is a more accurate way to reconcile 
medications than using chart lists; ‘brown bag requests' should be combined with structured 
interviewing. 
Vejar, Makic, & Kotthoff-Burrell (2014) conducted a more successful ‘brown bag’ 
quality improvement project.  During a 9-month period in a primary care setting that serves a 
patient population from ages 51 to 102, a pre and post intervention to improve medication 
reconciliation was conducted.  A key facet of the intervention was ‘brown bagging' or having the 
patients bring all of their prescription and over the counter medications to every visit.  Baseline 
data for patients who ‘brown bagged' their medications before the intervention was zero percent 
and post-intervention was 64%.The pre-intervention medication reconciliation rate was 64%, and 
post-intervention rose to 96%.  Educating patients and staff played a significant role in 
increasing reconciliation rates; the most effective tools included reminder notes posted in exam 
rooms for patients, monthly discussions with employees about compliance rates and automated 
phone reminders for patients to bring their medications to their visit. 
  The Institute for Healthcare Improvement (IHI) How-to Guide: Prevent Adverse Drug 
Events by Implementing Medication Reconciliation is an evidence-based protocol for 
implementing a medication reconciliation process at all transitions’ of care, including admission, 
transfer, discharge and ambulatory sites.  Based on Johns Hopkins Nursing Evidence Based 
Practice (JHNEBP) evidence rating scales (Newhouse, Dearholt, Poe, LC, & White, 2005) the 
strength of evidence is level 4, and quality of evidence is A.  This guideline advises on how to 
Conduct Medication Reconciliation Reviews, complete the medication reconciliation, reconcile 
differences as well as dealing with barriers.   
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 The Agency for Healthcare Research and Quality (AHRQ) Medications at Transitions 
and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation is an evidence-based 
toolkit based on processes developed in acute-care settings but with core processes, tools, and 
resources can be adapted for use in non-acute facilities. (Gleason KM, 2012).  Based on 
JHNEBP evidence rating scales (Newhouse, Dearholt, Poe, LC, & White, 2005), the strength of 
evidence is level 4, and quality of evidence is A.  The toolkit is a blueprint for developing a 
medication reconciliation process in order to gain a single, accurate list of patient medication that 
is referred to as, "the one source of truth" (p. 22). 
Evidence-Based Practice: Verification of Chosen Option 
 The AHRQ Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for 
Medication Reconciliation and the IHI How-to Guide: Prevent Adverse Drug Events by 
Implementing Medication Reconciliation will be used to provide a framework for developing a 
medication reconciliation process at a community-based outpatient psychiatric practice.    
Theoretical Framework/Evidence-Based Practice Model 
 Lippitt’s Phases of Change Theory (Mitchell, 2013), an extension of Lewin’s Three-Step 
Change Theory, will be used as a theoretical guide for this quality improvement project (see 
Appendix A).  Lippitt’s phases of change theory is commonly used in the nursing profession and 
focuses on the role and responsibility of change agent than the change itself; external change 
agents effect a change, the change agent relationship ends and in their place is the foundation for 
change to move forward (Anderson, 2015).  The four elements of Lippitt’s Theory are 
assessment, planning, implementation, and evaluation, all of which parallel the steps of the 
nursing process (assessment, diagnosis, outcomes/planning, implementation, evaluation) and 
therefore, lend themselves well to this quality project.  Within the four elements of Lippitt’s 
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Theory are seven phases that guide change: 
• Phase one: diagnose the problem 
• Phase two: assess motivation/capacity for change 
• Phase three: assess change agent’s motivation and resources 
• Phase four: select progressive change objective 
• Phase five: chose appropriate role of the change agent 
• Phase six: maintain change 
• Phase seven: terminate the helping relationship (Mitchell, 2013) 
As Melat-Ziegler (2005) explains, the seven phases “do not possess rigid boundaries, rather 
movement may flow back and forth between the phases” (p. 204).  The steps in Lippitt’s Theory 
were used as a guide in implementing this DNP project.    
Lippitt’s Seven Phases 
In the first three phases, change agents (management, practitioners) expressed their 
motivation to change, after they were made aware of the reasons (need) for change.  Through 
collaboration, the problems were identified, and the process of change was explained.  In phases 
four through six, change objectives in the reconciliation process were selected, the nurse’s (DNP 
student) role in the process was defined, and the change was initiated.  In the seventh and final 
phase, after successful integration of the change, the nurse implemented strategies to maintain 
the changes.  This final phase corresponds with Lewin’s ‘refreezing’ stage at which point, after 
finding a new way of  doing things is established, changes are made permanent (Mitchell, 2013) 
(Melat Ziegler, 2005).   
Goals, Objectives and Expected Outcomes 
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• With the assistance of management and staff, an evidence-based medication 
reconciliation project was implemented by DNP student 
• The goal was a 50% medication reconciliation completion rate 
• The intervention took place over a 2-month period during the months of December, 2017 
and January, 2018 
• After analysis of results, the objective was for an evidence-based medication 
reconciliation process to stay in place at the practice 
Project Design 
 Using a stepwise approach, the AHRQ Medications at Transitions and Clinical Handoffs 
(MATCH) Toolkit for Medication Reconciliation and the IHI How-to Guide: Prevent Adverse 
Drug Events by Implementing Medication Reconciliation, with a focus on ambulatory care, 
guided the implementation of this practice intervention.  The current medication reconciliation 
process was inefficient, therefore, this evidence-based quality improvement project aimed to 
improve patient safety through its initiation.   
Project Site and Population   
The project site for this quality improvement project was an ambulatory care, community 
mental health practice in Western Massachusetts that provides outpatient psychiatric services 
including psychotherapy, medication management, substance abuse treatment and crisis 
intervention for children to senior citizens.  Being a community practice, a significant portion of 
the clientele have state or federal sponsored (Medicaid and Medicare) insurance.  The practice 
served a total of 932 outpatient clients and 371 family stabilization clients in the past year.   
Compliance with scheduled appointments is an issue at this practice.  There is a small, 
core group of patients who either cancel their appointment with the medication provider at the 
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last minute or skip (no-show) their appointments all together.  Compliance with medication 
provider appointments was a hindrance to completing the medication reconciliation in office. 
Participants 
Education on the medication reconciliation process was provided to all supervisory staff 
and to all participants.  Participants who had appointments with the medication provider during 
the months of October and November, 2017 were asked if they are willing to participate in a 
medication reconciliation quality improvement project.  Upon approval, they were asked to bring 
medications (prescribed and OTC) and medication lists to a subsequent appointment so they may 
be reconciled.  Those who were not available during an appointment time were contacted by 
phone to inquire about their participation.  The end sample included twenty-five total patients.  
All participants were adults, over the age of 18.  Due to the potential for multiple medications 
being prescribed and an increased risk of inaccurate medication lists, emphasis was be placed on 
older patients (50+) with comorbid medical conditions.  
Setting facilitators and barriers 
Facilitators to the implementation of this quality improvement project included the 
willingness of management and staff to help initiate, facilitate and participate; including, the 
clinic director, an advanced nurse practitioner, and three outpatient therapy supervisors.  The 
clinic director oversaw and approved all aspects of project implementation.  Three outpatient 
supervisors provided feedback on the current process, helped with patient selection and provided 
feedback.  The nurse practitioner provided assistance, as needed, in recruiting patients for the 
intervention.  Barriers to implementation included patient refusal to participate, medication 
noncompliance, appointment non-compliance, inability to obtain medication lists from other 
providers and the overall increased probability of noncompliance in the psychiatric population.  
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Implementation Plan/Procedures 
• Approval was obtained from site clinic director 
• Institutional review board (IRB) approval was obtained 
• Coordinated with staff, identified team members and established roles 
• Goals and objectives determined 
• Timeline developed (Appendix E) 
• Flow chart for medication reconciliation process created(Appendix D) 
• Form created for taking medication histories (Appendix B) 
• Implementation strategy developed 
• Education provided to staff 
• Review patient databases/records for selection 
• Patient participant list created 
• Patient participation requested 
• Reminders sent to patients to bring medications and lists to visit 
• Releases of information (ROI) updated as necessary 
• Patients interviewed, medication bottles and lists reviewed 
• Medication information obtained from outside as necessary (providers/pharmacies) 
• Patient provided with updated and completed medication list (Appendix B) 
Measurement Instruments 
 In order measure the outcomes of this DNP project, pre and post medication 
reconciliation data was recorded to include: 
Qualitative data: 
• Patient gender  
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• Patient age 
• Brought medications for reconciliation (y/n) 
Quantitative data: 
• Number of no-show appointment in the previous year  
• Number of psychiatric medications  
• Number of non-psychiatric medications  
• Number of over the counter medications  
• Number of potential drug interactions total 
• Number of potential drug interactions between those medications that were in the 
medication profile with the number of medications that were not in the medication profile 
Data Collection Procedures  
 The Plan-Do-Check-Act (PDCA) Cycle guided this quality project.  The Plan-Do-Study-
Act (PDSA) cycle, part of the IHI Model for Improvement, is a tool for accelerating quality 
improvement by planning it, trying it, observing the results, and acting on what is learned 
(AHRQ, 2013).  The plan stage is recognizing an opportunity and planning a change.  The do 
stage involves testing the change and carrying out a small-scale study.  The check stage involves 
reviewing the test, analyzing the results and identifying what was learned. The act stage involves 
taking action based on what was learned and if the change did not work, going through the cycle 
again with a different plan.  If the plan was successful, incorporating what was learned into wider 
changes and using what was learned to plan new improvements then beginning the cycle again 
(American Society for Quality, 2017).    
Steps 
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After this DNP student had been seeing patients in the practice for over a year, it was 
apparent that EMR’s were not up to date with the most current medications and that the practice 
of mediation reconciliation was either inadequate or all together, absent.  It was at that time that 
this DNP project was conceived and brought to the attention of the clinic director.   
Team selection 
After assessing the needs and motivation to change, meetings were held with the clinic 
director, the outpatient therapy supervisors, therapists and nurse practitioner to discuss 
medication reconciliation as a process and to discuss the importance of keeping the EMR up to 
date with current medications.  Separate meetings were held with the practice’s compliance 
officer and Information Technology (IT) representative and the Manager of Integrated Services.  
Discussion was held with Manager of Integrated Services about potentially having a compliance 
report created for completion of the medication reconciliation process as well as a standardized 
electronic medication reconciliation form to be completed by the admitting clinician.   
Discussion was held with IT officer requesting to have more providers listed in the drop 
down list of prescribers; as the current system is built, the only providers who can be chosen are 
those who work for the organization.  Other providers must be listed in a free text field that is not 
visible unless a ‘+’ sign is clicked.  Meetings with supervisors included discussion about the 
process of medication reconciliation, the plans for the intervention as well as discussion about 
potential patients to be selected.   
Intervention 
 The patient population at the practice ranges from children as young as four to adults as 
old as seventy-five.  Although a large percentage of the patient population are only being 
prescribed psychiatric medications from the nurse practitioners in the practice, many of the older 
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adults have comorbid medical conditions and are on more than one medication from their 
medical providers; this was the population targeted for this intervention.  Thirty-five patients 
were selected to have their medications reconciled as per the AHRQ and INH Guidelines.  
During provider visits, the importance of maintaining updated medication lists was explained 
and selected patients were asked to participate in this intervention.  Additional patients were 
contacted by phone.  The initial plan was to have all patient’s medications reconciled in the 
office.   
 The reconciliation process began as an in-office intervention but due to appointment non-
compliance, extended to home visits.  In office or in home, prescription medication bottles were 
reviewed as well as over the counter medications.  Medication lists in the EMR were updated 
and release of information (ROI) were signed for primary care and specialty practices, as 
necessary.  Calls were placed to providers and pharmacies as necessary.  Patients were provided 
with medication lists and they were faxed to primary care practices as necessary.  For reasons 
including appointment non-compliance and inability to coordinate, by the end of intervention, 
twenty-five patient’s medication profiles were updated (71%) in the EMR.   
Data Analysis  
 Statistical Package for the Social Sciences (SPSS) version 24 was used for data analysis 
of the measurement instruments described previously.   
Cost-Benefit Analysis/Budget 
 This DNP project was executed almost exclusively by this DNP student.  Meetings with 
staff were conducted during normal operating hours and in most cases, during the course of 
already scheduled meetings.   
Timeline 
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 The timeframe for this intervention was from September, 2017 through April, 2018 (see 
Appendix E).  University of Massachusetts Amherst institutional review board (IRB) approval 
was sought in September 2017, and participant selection took place in October and November, 
2017.  Implementation and data collection took place during the months of December, 2017 
through January 2018.  Data analysis and completion of the final report will took place during 
the months of February and March, 2018.     
Ethical Considerations/Protection of Human Subjects 
Although the behavioral health practice does not currently use a formal medication 
reconciliation process, review of medications is part of every assessment or reassessment visit to 
the practice.  Since the collection of prescribed medication information is already part of a 
standard office visit, it is a service that is covered by the Health Insurance Portability and 
Accountability Act (HIPAA).  Since this intervention will take place as a matter of routine 
during office visits, it too will be covered by the same HIPAA practices and will introduce no 
further risk of harm to patients.  All current HIPAA practices at the practice will continue to be 
followed and patient data will be kept secure and protected.  In September, 2017, it was 
determined by of University of Amherst, Office of Research Compliance, that this DNP project 
did not meet the definition of human subject research thus, IRB approval and participant consent 
was not required.  
Results 
Pre-intervention Descriptive Statistics 
Sample 
 The final sample population for this DNP project included 25 adults, from a behavioral 
health practice in Western Massachusetts. The majority of whom have comorbid medical 
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conditions and with a mean age of 54 years (SD=5.1).  The sample included 20 females (80%) 
and five males (20%).   
Patient Compliance 
Patient compliance was evaluated using two methods. Initially, a patient was considered 
compliant if they brought in their medications as instructed for the medication reconciliation. 
Patient compliance was also evaluated by examining the number of times they did not show up 
(“no-show”) for their provider visit.   
Intervention compliance. Of the 25 total subjects, 12 (48%) brought their medications to 
their provider visit as instructed.   Just over one-half (52%) did not bring in their medications.  
This led to extending the intervention to a home visit for 13 patients so that medications were 
reconciled in their homes.  
Appointment compliance. The total number of no-show visits in the previous 12-months 
for all 25 subjects was 39 missed appointments.  Of the 13 subjects who had their medications 
reconciled in the home, the mean number of “no-show” visits were 2.2 (SD = 1.1).  The mean 
number of “no show” visits among those who did bring in their medications was significantly 
less with a mean of 0.8 (SD = 0.9, t = 3.4, p = 0.002). 
Medication Reconciliation 
As discussed in the intervention section, both prescription and over-the-counter 
medication bottles were reviewed and medication lists in the electronic medical record were 
updated based on this reconciliation process.  Paired sample T-tests (See Table 1) were 
performed to compare pre and post medication reconciliation differences between psychiatric 
medications, non-psychiatric medications and over-the-counter medications.  Results indicated 
that there was a significant difference between pre and post over-the-counter medications 
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(mean=2.28) and a very significant difference between pre and post non-psychiatric medications 
(mean=4.52).   
 
Table 1. Pre and post medication reconciliation paired sample statistics 
Medications N Mean SD t p 
Psychiatric  
   Pre reconciliation 25 2.8 1.2 
1.4 0.185 
   Post reconciliation  25 3.0 1.4 
Non-Psychiatric 
   Pre reconciliation 25 0.4 0.6 
8.2 <0.001*** 
   Post reconciliation  25 4.5 2.8 
OTC 
   Pre reconciliation 25 0.0 0.0 
4.6 <0.001*** 
   Post reconciliation  25 2.3 2.5 
  †p ≤ .10. *p ≤ .05. **p ≤ .01. ***p ≤ .001 
Drug Interactions 
Post medication reconciliation analysis used ANOVA to determine statistical differences 
between compliance groups (see Table 2).  Results indicated that the 12 in-office subjects had a 
mean of 3.4 non-psychiatric and 2.4 OTC medications missing from their EMR; those 13 who 
had their medications reconciled in home had a mean of 5.5 non-psychiatric and 2.2 OTC 
medications missing from their EMR.  There was clinical significance (p= 0.052) between the in-
office and home visit compliance group with reconciled non-psychiatric medications with a 
mean of 5.5 medications among the home group and 3.4 among those that brought in their 
medications with a large effect size (0.82) supporting that many non-psychiatric medications are 
not accounted for in the medication profiles of patients. 
Results further indicated that those who had their medications reconciled in home had a 
total higher risk (mean=1.5) of potential medication interactions.  Although under-powered 
(would need N=62 to be a statistically significant result) the large effect size of 0.72 (based on 
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Cohen’s d), when comparing drug interactions between those who did and did not bring their 
medications to office for reconciliation, indicates a result that is clinically significant.   
 
 Table 2. Post Med Reconciliation Analysis by Compliance Group 
Medication Type  Compliance Group N Mean SD F p d 
Reconciled non-
psychiatric 
medications 
1 (brought) 12 3.4 2.8  
4.192 
 
0.052 
 
0.82 2 (home) 13 5.5 2.4 
Total  25 4.5 2.8 
Reconciled 
psychiatric 
medications 
1 12 2.7 1.4  
1.015 
 
0.324 
 
0.40 2 13 3.2 1.4 
Total 25 3.0 1.4 
Reconciled OTC 
medications 
1 12 2.4 3.2  
0.068 
 
0.797 
 
0.10 2 13 2.2 1.6 
Total 25 2.3 2.5 
Potential drug 
interactions- 
total 
1 12 0.6 0.9  
3.242 
 
0.085 
 
0.72 2 13 1.5 1.5 
Total 25 1.0 1.3 
Potential drug 
interactions- 
drugs not in 
EMR 
1 12 0.3 0.8  
0.202 
 
0.657 
 
0.18 2 13 0.5 1.4 
Total 25 0.4 1.1 
 
Clinical Relevance 
 Overall, patients who did not bring their medications to the office for reconciliation had 
more appointment no-shows and had a higher potential for drug interactions; this sub-group was 
also prescribed more medications and used more OTC medications, overall.  This could be a 
significant finding in treating a vulnerable population such as behavior health patients.  Whether 
homebound due to medical health issues, mental health issues, substance abuse issues, 
inadequate finances (transportation) or other, they may be at higher risk for adverse outcomes.  
This highlights the potential need for home health interventions, including medication 
reconciliation.   
Discussion 
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Through this intervention, a 71% medication reconciliation completion rate was 
achieved; more than the 50% goal that was set.  Results reflected that each patient had at least 
one medication missing from their EMR and that overall, there were a significant number of 
medications missing.  After medication reconciliation was completed: 
• A total of 103 (mean 4.1) additional non-psychiatric medications were entered into the 
medication profiles; this increased the total number of psychiatric medications in the 
medication profile for all patients from 10 to 113 (see Table 3). 
 
Table 3. Pre and post medication reconciliation non-psychiatric medications 
 
• A total of 57 (mean 2.3) over the counter medications (OTC and supplements) were 
entered into the medication profiles; this increased the total number of OTC medications 
in the medication profile for all patients from 0 to 57 (see Table 4). 
 
Table 4. Pre and post medication reconciliation OTC 
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• Those 12 who brought their medications to the office for reconciliation had a mean of 
3.42 non-psychiatric medications and 2.42 OTC medications missing from their 
medication profiles. 
• Those 13 who had their medications reconciled in the home with a mean of 5.54 non-
psychiatric medications and 2.15 OTC medications missing from their medication 
profiles (see Table 5). . 
Table 5. Mean difference between in office and in home reconciliation 
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Potential Drug Interactions: 
As discussed previously, medication errors and adverse drug interactions are of particular 
concern in healthcare today.  In light of that, it was of particular interest that through this 
intervention, several potential drug interactions were identified.  In all, 26 potential drug 
interactions were identified; eleven of those were between medications already in the medication 
profile with those not in the medication profile.   
• Those 13 who had their medications reconciled in the home had a mean of 1.46 for total 
potential drug interactions and a mean of 0.54 for potential drugs in the EMR with those 
not previously in the EMR.   
• Those 12 who brought their medications to the office for reconciliation had a mean of 
0.58 for total potential drug interactions and a mean of 0.33 for potential drug interactions 
between drugs in the EMR with those not previously in the EMR (see Table 6). 
Table 6. Potential Drug Interactions In-Home vs. In-Office 
 
Overall results reflected that those who were reconciled at home had more missing 
medications (mean 5.54 vs 3.42) in the EMR as well as a higher potential for total drug 
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interactions (mean 1.46 vs 0.54).   Those results highlight why patients are at such increase risk 
when medication reconciliation is not performed correctly and why the World Health 
Organization named it as one of five top patient safety strategies.   
Suggestions and Future Recommendations 
There was clearly a practice gap in this mental health practice in the area of medication 
reconciliation.  Not only was there a practice gap but there was also a knowledge gap amongst 
the staff and one could even say, among the organization as a whole.  Although reconciling 
medications was a part of admitting new patients to the practice, it was not executed thoroughly 
and completely to create the “one source of truth.”  With education, however, the staff at the 
practice were found to be very receptive about improving the process; or as Lippitt describes it, 
they had to motivation and capacity to change.   
Conclusion 
  Increasing rates of chronic illness have resulted in an increase in the complexity of 
medication regimens.  Patients are having medications prescribed in acute care facilities, skilled 
nursing facilities and in multiple outpatient settings, thereby opening up the potential for an 
increased risk of adverse drug events (ADE).  Adverse drug reactions represent a serious and in 
many cases, preventable, public health problem that can lead to illness, disability, and death.  
Medication reconciliation is a process that can help reduce the potential for adverse drug events.  
When medications are reconciled accurately in an outpatient setting, a best possible medication 
history is created.   
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Appendix A 
Lippitt’s Phases of Change Theory 
 
 
 
Mitchell, G. (2013). Selecting the best theory to implement planned change. Nursing 
Management, 20(1), 32-37. 
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                     MEDICATIONS                                                              Appendix B                                                            Patient Name: 
  
Start 
Date 
Name of Medication Prescribed By Dosage When is the 
Medication 
Taken 
Purpose Danger Signs* Notes/ Changes 
mm/dd/yy Brand and Generic name 
(If available) 
 mg/ units/ 
puffs/ drops 
How many times 
per day? 
Morning and/or 
night? After 
meals? 
 Call Immediately if 
you experience any 
of these signs 
Drugs and/or food that may cause 
interactions. Date list was 
reviewed/updated 
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Appendix C 
Citation Sample/location Design Outcomes/results Strengths/weakness Evidence Level 
Nassaralla, C., 
Naessens, J., Hunt, 
V., Bhagra, A., 
Chaudhry, R., 
Hansen, M., & 
Tulledge-Scheitel, 
S. (2008). 
Medication 
reconciliaiton in 
ambulatory care: 
attempts at 
improvement. 
Quality Safety 
Healthcare, 402-
407. 
doi:10.1136/qshc.20
07.024513 
 
Sample: 
pre and post 
intervention  
N=325 
 
 
 
Location: 
Four academic 
ambulatory, primary 
care medicine 
clinics 
Patients were 
selected by using 
random numbers 
 
Patients received 
an LPN-guided 
‘patient 
awareness’ 
intervention about 
the medication 
reconciliation 
process 
 
Impact of 
intervention 
assessed post-
intervention 
Completeness of 
medication lists 
improved from 
20.4% pre-
intervention to 50.4% 
post-intervention  
 
Patient participation 
in the medication 
reconciliation process 
increased from 
13.9% to 33%; lastly, 
medication list 
accuracy improved 
from 11.5% to 29%.   
 
 
Strengths:  
Few patients met the 
exclusion criteria 
It’s possible to improve 
accuracy of medication 
lists with low a 
technology solution 
Weaknesses: 
No control group to 
compare with post-
intervention group 
Conducted among four 
practice settings that may 
not generalize to other 
settings 
3         B 
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Citation Sample/location Design Outcomes/results Strengths/weakness Evidence Level 
Keogh, C., Kachalia, 
A., Fiumara, K., 
Goulart, D., Coblyn, 
J., & Desai, S. 
(2016). Ambulatory 
medication 
reconciliation: 
Using a 
collaborative 
approach to process 
improvement at an 
academic medical 
center. The Joint 
Commision, 186-
192. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22,884 patient visits 
per month three 
months of 2013; 
256,800 patient 
visits nine months of 
2014 (1 yr. study 
period). 
 
Location: 
148 Brigham and 
Women’s Hospital 
ambulatory care 
practices in Boston  
Pilot study  and 
Institutional 
collaborative 
improvement 
project 
Three levels 
(rigorous, 
modified, less 
intensive) of 
interventions  that 
centered on staff 
education were 
implemented 
 
 
 
 
From pre to post-
intervention, 
improvement from 
71% to 90% in 
specialty practices 
and from 62% to 
91% in primary 
care practices and 
across all 
ambulatory 
practices increased 
from 81% to 90%.   
Strengths: 
Use of a collaborative 
model that aligned with 
policy, EHR tools and 
reliable electronic 
measurement 
 
Weaknesses: 
Pressure on provider 
time affected attendance 
in collaborative sessions 
 
Financial incentive added 
in final phases 
 
 
3        B 
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Citation Sample/location Design Outcomes/results Strengths/weakness Evidence Level 
Milone, A., 
Philbrick, A., & 
Harris, I. F. (2014). 
Medication 
reconciliation by 
clinical pharmacists 
in an outpatient 
family medicine 
clinic. Journal of 
the American 
Pharmacists 
Association, 181-
187. 
doi:10.1331/JAPhA
.2014.12230 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N=327  
 
 
 
 
 
 
Location: 
Family Medicine 
Clinic in St. Paul, 
MN 
 
 
 
 
 
Non-experimental 
research is the label 
given to a study 
Pharmacist-led 
intervention.  
Before seeing the 
physician, the 
clinical pharmacist 
consulted with each 
patient and 
reviewed their 
medication list and 
made corrections as 
necessary.  
2,167 discrepancies 
were identified and 
resolved; 51.1% 
were clinically 
important 
Strengths: 
High number of 
patients seen, 
resulting in large 
number of 
discrepancies and 
ability to categorize 
them 
Weaknesses: 
Time spent on each 
visit not recorded 
Subjective nature of 
data points (patient 
knowledge status, 
clinical importance of 
discrepancy  
3            B 
  MEDICATION RECONCILIATION     37 
Citation Sample/location Design Outcomes/results Strengths/weakness Evidence Level 
Sarzynski, E., Luz, 
C., Rios-Bedoya, 
C., & Zhou, S. 
(2014). 
Considerations for 
using the 'brown 
bag' strategy to 
reconcile 
medications during 
routine outpatient 
office visits. 
Quality in Primary 
Care, 177-187. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N=46; cognitively 
intact elders 
Mean age 79.8 yrs 
 
 
 
 
 
University-
affiliated 
community 
geriatric clinic 
 
 
Cross sectional 
pilot study 
 
Half of the 
participants were 
asked to ‘brown 
bag' (bring their 
medication bottles 
with them to the 
appointment) 
 
The other half were 
‘non-brown 
baggers.'   
61% of ‘brown 
baggers’ (BB) did 
not bring all their 
medications to their 
appointment 
6.5% of chart 
medication lists 
were correct 
BBs reported 
having had a 
comprehensive 
med review vs. 
NBB which 
suggests the value 
of the BB strategy 
 
Strengths: 
Brown baggers had 
comprehensive med 
reviews 
Weaknesses: 
Low compliance with 
brown bagging 
Partial brown baggers 
not differentiated 
from those who 
brought all meds 
Time-consuming 
process 
3           C 
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Citation Sample/location Design Outcomes/results Strengths/weakness Evidence Level 
Vejar, M., Makic, 
M., & Kotthoff-
Burrell, E. (2014). 
Medication 
management for 
elderly patients in 
an academic 
primary care 
setting: A quality 
improvement 
project. Journal of 
the American 
Association of 
Nurse Practitioners, 
72-78. 
doi:10.100212327-
6924.12121 
1580 chart audits 
903 patient 
questionnaires 
 
 
 
 
 
 
 
 
Senior clinic within 
a large academic 
setting 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quality 
improvement 
project 
Medication 
reconciliation 
compliance 
increased from 
64% to 96% 
 
Patients who 
brought their 
medications to visit 
increased from 0% 
to 64% 
 
Strengths: 
Increased awareness 
among providers of 
importance of med 
management in PCP 
setting 
 
Improved med 
management enabled 
the clinic to reach the 
national standards for 
medication 
reconciliation 
3              B 
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Appendix E 
 
Timeline 
 
 
 
Task October November December January February March April 
Patient 
selection 
X X      
Intervention   X X    
Data analysis 
and final 
report 
    X X X 
 
 
 
 
 
 
